Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
8.12 USD | +2.27% |
|
+5.18% | +19.59% |
06-24 | Byrna Technologies Names Lauri Kearnes CFO | MT |
06-19 | Harte Hanks Launches Demand Generation in a Box | CI |
Summary
- Overall, and from a short-term perspective, the company presents an interesting fundamental situation.
Strengths
- The equity is one of the most attractive in the market with regard to earnings multiple-based valuation.
- The company shows low valuation levels, with an enterprise value at 0.19 times its sales.
- Analysts have consistently raised their revenue expectations for the company, which provides good prospects for the current and next years in terms of revenue growth.
- For the past twelve months, EPS forecast has been revised upwards.
- The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
- The average price target of analysts who are interested in the stock has been strongly revised upwards over the last four months.
- The group usually releases upbeat results with huge surprise rates.
Weaknesses
- With relatively low growth outlooks, the group is not among those with the highest revenue growth potential.
- As a percentage of sales and without taking into account depreciation and amortization, the company has relatively low margins.
- The company does not generate enough profits, which is an alarming weak point.
- For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
- The price targets of various analysts who make up the consensus differ significantly. This reflects different assessments and/or a difficulty in valuing the company.
Ratings chart - Surperformance
Sector: Advertising & Marketing
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+19.59% | 57.49M | - | ||
+2.88% | 2.24B | B- | ||
-32.55% | 459M | - | - | |
-23.55% | 440M | - | - | |
+24.18% | 411M | - | - | |
-1.91% | 144M | C | ||
-52.31% | 109M | - | - | |
+4.67% | 107M | - | - | |
+54.83% | 85.54M | - | ||
+5.39% | 85.44M | - | - |
Financials
Valuation
Momentum
Consensus
Business Predictability
- Stock Market
- Equities
- HHS Stock
- Ratings Harte Hanks, Inc.